title: Inhibitory effect of the newly synthesized pyridazinone derivative NZ-107 on bronchoconstriction induced by slow reacting substance of anaphylaxis in the guinea pig.
abstract: We have investigated the effect of a newly synthesized compound NZ-107, 4-bromo-5-(3-ethoxy-4-methoxybenzylamino)-3(2H)-pyridazinone, on bronchoconstriction induced by slow reacting substance of anaphylaxis (SRS-A) in the guinea pig. Orally administered NZ-107 (10 mg/kg, 2 hr) inhibited antigen-induced SRS-A-mediated bronchoconstriction in sensitized guinea pigs. NZ-107 (2 mg/kg, i.v., 1 min) prevented the antigen-induced response about as well as the SRS-A antagonist FPL-55712 and rapidly reversed it. This rapid reversal by NZ-107 but not FPL-55712 also appeared with the leukotriene (LT) D4-induced contraction of the isolated trachea. NZ-107 more selectively inhibited the LTD4 response than those of histamine, acetylcholine and KCl. Compared to FPL-55712, NZ-107 was one-fifteenth less potent in inhibiting the LTD4 response, but two-fold more potent in inhibiting the LTC4 response. NZ-107 inhibited the LTD4 response of the trachea 10-fold more potently than that of the ileum (-log IC50: trachea 5.61, ileum 4.56). The combination of NZ-107 (1 microM) with the beta-agonist isoproterenol had no synergistic effect on the LTD4 response, but those of theophylline and papaverine had large effects. From these results, NZ-107 is a selective inhibitor of the SRS-A response and may be useful in the therapy of bronchial asthma and other diseases in which the LTs are thought to be involved.
authors.affiliation: Shiraoka Research Station of Biological Science, Nissan Chemical Ind., Ltd., Saitama, Japan.
authors.forename: M
authors.initials: M
authors.lastname: Hibi
authors.forename: K
authors.initials: K
authors.lastname: Shikada
authors.forename: T
authors.initials: T
authors.lastname: Iwama
authors.forename: A
authors.initials: A
authors.lastname: Yamamoto
authors.forename: M
authors.initials: M
authors.lastname: Sakashita
authors.forename: S
authors.initials: S
authors.lastname: Tanaka
mesh_terms: D000818:Animals; D000941:Antigens / Q000276:immunology; D001980:Bronchi / Q000187:drug effects*; D003250:Constriction; D004336:Drug Antagonism; D006168:Guinea Pigs; D008297:Male; D009130:Muscle, Smooth / Q000187:drug effects; D011724:Pyridazines / Q000494:pharmacology*; D013189:SRS-A / Q000494:pharmacology*
chemical_list: D000941:Antigens; D011724:Pyridazines; D013189:SRS-A; C062698:NZ 107